Archive ready

自主回収｜クラス１｜報道発表資料｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_07124.html

April 9, 2026 at 03:00 PM JST•The archive page, viewer, and downloads use this saved version.

April 9, 2026 at 03:00 PM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

自主回収｜クラス１｜報道発表資料｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_07124.html

StartedApril 9, 2026 at 03:00 PM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces the voluntary recall of pharmaceuticals by Takeda Teva Pharma Co., Ltd. The company has initiated recalls of Ranitidine Tablets 75mg and 150mg "Taiyo" and Ranitidine Injections 50mg and 100mg "Taiyo". This is classified as Class I, the most serious recall category. The notice was issued on October 3, 2019, by Japan's Ministry of Health, Labour and Welfare. Contact information for the Surveillance and Control Division and the Pharmaceutical Safety Division is provided. Further details are available in Takeda Teva Pharma's press release.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.